Trial intelligence / Profile preview

Losartan Dose-Ranging in Pediatric Hypertension

NCT00756938Phase 3Completed

Sponsor
Organon & Co.
Start
Mar 2009
Primary completion
Aug 2012
Modality
Small Molecules
01

Overview

A Phase 3 trial of losartan in hypertension (HTN), sponsored by Organon & Co.. Started Mar 2009; status: completed.

02

Drugs

losartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00756938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00756938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call